Transdermal Skin Patches Market Report 2024: Size, Share, Growth, Trends, Forecast 2033

The new report published by The Business Research Company, titled Transdermal Skin Patches Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033, delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.

As per the report, the transdermal skin patches market size has grown steadily in recent years. It will grow from $7.36 billion in 2023 to $7.67 billion in 2024 at a compound annual growth rate (CAGR) of 4.2%. The transdermal skin patches market size is expected to see steady growth in the next few years. It will grow to $9.02 billion in 2028 at a compound annual growth rate (CAGR) of 4.1%.

Download Free Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=2829&type=smp

Rising Prevalence Of Cardiovascular Disease Boosts Transdermal Skin Patches Market
The increasing prevalence of cardiovascular disease is expected to propel the growth of the transdermal skin patches market going forward. Cardiovascular diseases are ailments that have an impact on the heart and blood vessels. The development of fatty deposits inside the arteries (atherosclerosis) and a higher risk of blood clots are typically connected with it. Transdermal skin patches are used to prevent episodes of angina (chest pain) in people who have coronary artery disease (narrowing of the blood vessels that supply blood to the heart). These are also used to improve bioavailability for the treatment of heart failure. For instance, in May 2023, according to the Centers for Disease Control and Prevention, a US-based public health agency, about 695,000 people in the United States died from heart disease in 2021-that's 1 in every 5 deaths. Coronary heart disease is the most common type of heart disease, killing 375,476 people in 2021. Therefore, the increasing prevalence of cardiovascular disease is driving the growth of the transdermal skin patches market.

Innovation Key For Competitive Edge In Transdermal Skin Patches Market
Major companies operating in the transdermal skin patches market are increasing their focus on introducing innovative products and getting them approved to gain a competitive edge in the market. Innovative products refer to offering new or improved solutions, such as drugs, medical devices, or other products, to existing problems or needs. For instance, in March 2022, Noven Pharmaceuticals Inc., a US-based pharmaceutical company, announced the U.S. Food and Drug Administration's (FDA), a US-based federal agency, approval of the XELSTRY (dextroamphetamine) transdermal system. It is the first and only approved amphetamine patch for the treatment of ADHD (Attention-Deficit or Hyperactivity Disorder). XELSTRYM should be used two hours before an effect is required, and it should be eliminated nine hours later. Depending on the clinical response and tolerability, the final dosage should be tailored.

The transdermal skin patches market covered in this report is segmented -
1) By Product: Matrix, Drug In Adhesive, Reservoir, Vapor
2) By Type: Fentanyl Transdermal Patch, Nicotine Transdermal Patch, Estradiol Transdermal Patch, Clonidine Transdermal Patch, Testosterone Transdermal Patch, Other Types
3) By Distribution Channel: Pain Relief, Nicotine Cessation,Hormone Replacement Therapy, Neurological Disorders, Cardiovascular Disorders, Other Applications

Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=2829&type=discount

Major companies operating in the transdermal skin patches market report are Novartis, Hisamitsu Pharmaceutical Co., Inc, Henan Lingrui Pharmaceutical, Teva Phamaceuticals, Luye Pharma Group Ltd, Purdue Pharma L.P., Nitto Denko Corporation, AdhexPharma, Noven Pharmaceuticals, Teikoku Pharma, Mylan Pharmaceuticals Inc, 3M Company, Acrux Ltd, Access Pharmaceuticals Inc, Rusan Pharma, Glenmark Pharmaceuticals, Cipla Ltd, Mundipharma, Dr Reddy's Laboratories, Chattem, Clarity Medical, Welcare Industries S.P. A, F.L. Medical S.r.l, Empire MEDICAL UK LTD, Europlaz Technologies Ltd, Zentiva, Alfa-Med LLC, Medplant LLC, Medical-Łomża Sp. z o.o., P.H.U. Medical, ProVeterináře, Panop CZ, Allergan Inc., Johnson & Johnson, Boehringer Ingelheim GmbH, Bayer AG, Bristol-Myers Squibb Company, GlaxoSmithKline plc, Echo Therapeutics Inc, Endo Pharmaceuticals Inc.

Contents of the report:
1. Executive Summary
2. Transdermal Skin Patches Market Report Structure
3. Transdermal Skin Patches Market Trends And Strategies
4. Transdermal Skin Patches Market - Macro Economic Scenario
5. Transdermal Skin Patches Market Size And Growth
…..
27. Transdermal Skin Patches Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Explore the report store to make a direct purchase of the report @ https://www.thebusinessresearchcompany.com/report/transdermal-skin-patche-global-market-report

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ "

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.